W M Gonsalkorale

Summary

Publications

  1. ncbi Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, United Kingdom
    Am J Gastroenterol 97:954-61. 2002
  2. ncbi Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Manchester, UK
    J Psychosom Res 56:271-8. 2004
  3. ncbi Hypnotherapy in the treatment of irritable bowel syndrome
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, UK
    Eur J Gastroenterol Hepatol 17:15-20. 2005
  4. ncbi Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Manchester, UK
    Int J Clin Exp Hypn 54:27-50. 2006
  5. pmc Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?
    W M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Nell Lane, Manchester M20 2LR, UK
    Gut 52:91-3. 2003
  6. pmc Long term benefits of hypnotherapy for irritable bowel syndrome
    W M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Manchester, UK
    Gut 52:1623-9. 2003
  7. ncbi Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome
    R Lea
    Academic Department of Medicine, University Hospital of South Manchester, UK
    Aliment Pharmacol Ther 17:635-42. 2003

Collaborators

Detail Information

Publications7

  1. ncbi Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, United Kingdom
    Am J Gastroenterol 97:954-61. 2002
    ..This study presents an audit on the first 250 unselected patients treated, and these large numbers have also allowed analysis of data in terms of a variety of other factors, such as gender and bowel habit type, that might affect outcome...
  2. ncbi Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Manchester, UK
    J Psychosom Res 56:271-8. 2004
    ....
  3. ncbi Hypnotherapy in the treatment of irritable bowel syndrome
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, UK
    Eur J Gastroenterol Hepatol 17:15-20. 2005
    ....
  4. ncbi Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome
    Wendy M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Manchester, UK
    Int J Clin Exp Hypn 54:27-50. 2006
    ..Other interventions based on particular lifestyle and psychological factors commonly found to influence symptoms are also included as appropriate for the individual patient...
  5. pmc Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?
    W M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Nell Lane, Manchester M20 2LR, UK
    Gut 52:91-3. 2003
    ....
  6. pmc Long term benefits of hypnotherapy for irritable bowel syndrome
    W M Gonsalkorale
    Department of Medicine, University Hospital of South Manchester, Manchester, UK
    Gut 52:1623-9. 2003
    ..However, there is no long term data on its benefits and this information is essential before the technique can be widely recommended. This study aimed to answer this question...
  7. ncbi Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome
    R Lea
    Academic Department of Medicine, University Hospital of South Manchester, UK
    Aliment Pharmacol Ther 17:635-42. 2003
    ..In addition, the study group was symptomatically rather than physiologically defined...